Remove Funding Remove Technology Remove Thousand Oaks
article thumbnail

Atara Biotherapeutics Gets Funding From Amgen, KPCB

socalTECH

Thousand Oaks-based Amgen and venture firm Kleiner Perkins Caufield & Byers have put their backing behind a new, Westlake Village based drug development firm, Atara Biotherapeutics , in an unusual spinout of technology from the biotech giant. Financial details of the funding were not announced.

article thumbnail

Ceres Raises $20M

socalTECH

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Source of the new funding was not disclosed. The filing indicates the round came from five investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ImmunGene Raises $9M

socalTECH

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.

article thumbnail

Amgen Backs New $315M Life Sciences Fund

socalTECH

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund. READ MORE>>.

article thumbnail

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

article thumbnail

Ceres Details Financing Round

socalTECH

Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. The funding came from Artal Luxembourg, Ambergate Trust, Gimv, and other undisclosed investors. Ceres is developing improved seed varieties--including. READ MORE>>.

article thumbnail

Reflections on 2019: Greg Monterrosa, Startup Community Leader

socalTECH

Every year, at the end of the year, we share some reflections on the past year from our readers, entrepreneurs, venture capitalists, sponsors, and others in the local technology community. Many jobs have been created and companies have received funding through our efforts of supporting and bringing value to founders.

Startup 196